CVA Family Office’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520 Sell
46
-93
-67% -$1.16K ﹤0.01% 1728
2026
Q1
$1.82K Buy
+139
New +$2.45K ﹤0.01% 1548
2025
Q4
Sell
-17
Closed -$511 1334
2025
Q3
$511 Hold
17
﹤0.01% 1242
2025
Q2
$713 Buy
17
+3
+21% +$108 ﹤0.01% 1149
2025
Q1
$440 Buy
+14
New +$525 ﹤0.01% 1344
2024
Q3
Sell
-32
Closed -$842 1310
2024
Q2
$842 Buy
+32
New +$767 ﹤0.01% 1099
2022
Q4
Sell
-37
Closed 980
2022
Q3
$0 Hold
37
﹤0.01% 901
2022
Q2
$0 Hold
37
﹤0.01% 947
2022
Q1
$0 Sell
37
-160
-81% -$2.41K ﹤0.01% 971
2021
Q4
$4K Buy
+197
New +$4.25K ﹤0.01% 779

Other funds holding KD

CVA Family Office's KD Position: Q2 2026 in Review

CVA Family Office reduced its Kyndryl (KD) stake by 67% in Q2 2026, selling an estimated $1.16K and leaving 46 shares worth $520. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

CVA Family Office first reported a position in KD in Q4 2021 and has held it in 10 quarters since. The position peaked at $4K in Q4 2021. 671 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • CVA Family Office held 46 shares of Kyndryl worth $520 as of Q2 2026.
  • CVA Family Office sold 93 Kyndryl shares in Q2 2026, an estimated $1.16K.
  • Kyndryl made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1728 holding.
  • CVA Family Office first reported a position in Kyndryl in Q4 2021 and has held it in 10 quarters since.
  • CVA Family Office's Kyndryl position peaked at $4K in Q4 2021.
  • 671 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.